Jamie Cesanek

Where do you turn when your child is diagnosed with a rare cancer? In this two-part episode of the “CURE® Talks Cancer” podcast, a family shares the harrowing experience of learning their nine-year-old had neuroendocrine cancer.

The FDA has granted approval to Jakafi (ruxolitinib) for the treatment of chronic graft-versus-host disease (GVHD).

Sierra Oncology completed enrollment for its phase 3 MOMENTUM clinical trial for the treatment of patients with myelofibrosis.

The CURE® Poetry Contest winners explain what inspired each of their poems, from the death of a friend and oncologist who treated one survivor’s cancer to the emotional experience of losing hair during treatment.

From Jeff Bridges achieving remission from cancer to a cancer survivor who became a runway model, here’s what’s happening in the cancer landscape this week.

The FDA’s approval of Exkivity marks the first approved oral therapy for this subgroup of patients with non-small cell lung cancer.

An expert explains the treatment options and personal life impacts of an essential thrombocythemia diagnosis.

Norm Macdonald, known for his work on “Saturday Night Live,” has died from cancer that was kept private for nine years.

Retired FDNY firefighter and lung cancer survivor Jerry Sanford spoke about how he helped the rescue efforts following the Sept. 11 terrorist attacks in New York City.

From Senator Amy Klobuchar’s breast cancer experience to a 14-year-old survivor’s charity work for other children with cancer, here’s what’s happening in the cancer landscape this week.

An expert from Mount Sinai shares his account of Sept. 11, 2001, and describes how the toxins released as a result of the attacks have long-term health impacts.

From the death of Gregg Leakes to the effects of Hurricane Ida on a patient with stage 4 cancer, here’s what’s happening in the cancer landscape this week.

Dr. Curtis Mack shares the story of his cancer diagnosis and treatment journey in this episode of the “CURE® Talks Cancer” podcast. The oncologist describes the way it impacted his patient care.

Patients with Bacillus Calmette Guérin-unresponsive carcinoma in-situ will be treated at the University of Chicago in a Theralase study.

Olympic triathlete Kevin McDowell explains how certain aspects of surviving cancer and training for the Olympics became intertwined throughout his journey.

The first patient with HPV-positive head and neck squamous cell carcinoma received their dose of in the CUE-101 phase 1b trial.

Clinical trials are an invaluable resource to the cancer community, as they continually advance treatment options for patients. An expert explains how they work and what patients should know.

From the New York City chef who cooks for patients with cancer to a patient with cancer being turned away due to an increase in COVID-19 cases, here’s what’s happening in the cancer landscape this week.

In this episode of the “CURE® Talks Cancer” podcast Mel Mann discusses his participation in the clinical trial for Gleevec and how it changed the trajectory of his life.

Aggressive treatment based solely on the age of a patient with colorectal cancer is not warranted, a study found.

The FDA granted approval to Opdivo as an adjuvant treatment in patients with high-risk urothelial carcinoma.

From Dick Vitale’s early melanoma cancer detection to the authorization of COVID-19 vaccine booster shots for patients with cancer, here’s what’s happening in the cancer landscape this week.

In this episode of the “CURE® Talks Cancer” podcast, Olympic triathlete Kevin McDowell discusses his cancer journey and shares some insight on his experiences at the Tokyo 2020 Olympics.

Patients with non-small cell lung cancer had rapid uptake of immunotherapy-containing regimens, but a shorter overall survival than patients in clinical trials.

Mel Mann, the longest living person who participated in the clinical trial for Gleevec – which was approved by the FDA just over 20 years ago – shares what he would tell his younger self.

Liposarcoma survivor Arianne Missimer discusses the training process for ‘American Ninja Warrior’ and how she felt the day of competition.

The location of gastrointestinal stromal tumors in the stomach predicts the mutation profile and drug sensitivity, which can provide direction for treatment decisions and selective genomic testing.

From the state of the “Tiger King’s” Joe Exotic’s prostate cancer to the emotional reunion of two 3-year-old cancer survivors, here’s what’s happening in the cancer landscape this week.

In this episode of the “CURE® Talks Cancer” podcast, the hosts of the ‘Stage 4 Clinger’ podcast share the story of their cancer and caregiver journeys and how it led to the conception of their podcast.

Cancer survivors who identify as LGBTQ reported a lack of access to tailored resources and support groups and fear of discrimination.